Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$20.27 - $22.67 $201,058 - $224,863
-9,919 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$19.14 - $21.44 $189,849 - $212,663
9,919 New
9,919 $213,000
Q4 2018

Feb 01, 2019

SELL
$13.99 - $20.35 $189,312 - $275,376
-13,532 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$18.89 - $20.49 $36,986 - $40,119
1,958 Added 16.92%
13,532 $276,000
Q2 2018

Jul 20, 2018

BUY
$18.13 - $19.4 $2,248 - $2,405
124 Added 1.08%
11,574 $217,000
Q1 2018

Apr 18, 2018

SELL
$18.92 - $21.52 $23,347 - $26,555
-1,234 Reduced 9.73%
11,450 $220,000
Q4 2017

Jan 17, 2018

BUY
$18.31 - $22.24 $29,021 - $35,250
1,585 Added 14.28%
12,684 $249,000
Q3 2017

Oct 17, 2017

BUY
$20.12 - $21.88 $223,311 - $242,846
11,099
11,099 $238,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.